Arovella Therapeutics

Industry Lists

Arovella Therapeutics, formerly SUDA Pharmaceuticals, is a former Perth-based, ASX-listed pharmaceutical company.

Originally focused solely on oro-mucosal drug delivery, the company changed its name to Arovella following the acquisition of the iNKT cell therapy platform for cancer treatment.

Its two focus areas are oncology and conditions that impact the central nervous system.

Contact Details

Level 1, Unit 12, 55 Howe Street, OSBORNE PARK WA 6017

08 6142 5555

info@arovella.com

www.arovella.com

Lists and Charts

Share Price

Closing price for the last 90 trading days

View Full Chart

Share Transactions

28/03/24

$10k Bought

Gary Phillips

28/03/24

$15k Bought

Tom Duthy

29/12/23

$0 Bought

Michael Baker

Total value as at the date of the transaction

Revenue

Rank	Company	Revenue
974^th	Arovella Therapeutics	$1.5m
1173^rd	Real Energy Corporation	$11k
1176^th	Peako	$8k
1183^rd	Bentley Capital	$2k
1186^th	Orion Metals	$1k

View Full List

1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®

Total Shareholder Return as at 29/02/24

Rank	Company	1 yr	5 yr
10^th	Arovella Therapeutics	432%	110%
685^th	Orion Metals	0%	34%
955^th	Bentley Capital	-15%	-14%
1708^th	Peako	-67%	-20%

1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®

Collapse All Lists and Charts

Company Activity

	NEWS: Tagged in Board Moves March 13, 2023	13 Mar 2023
	NEW ROLE: Tom Duthy, Non-Executive Chair	13 Mar 2023
	ECM DEAL: New deal has been added	07 Mar 2023
	NEW ROLE: Nicole van der Weerden, Chief Operating Officer	04 Jan 2023
	ADDED: Added to Public Companies - non WA list	26 Oct 2022
	NEWS: Tagged in Arovella to shut Perth R&D facility	26 Oct 2022
	NEWS: Tagged in Board Moves July 1, 2022	01 Jul 2022
	NEW ROLE: Gary Phillips, Non-Executive Director	01 Jul 2022
	NEWS: Tagged in Board Moves June 7, 2022	07 Jun 2022